Vaccination with the Secreted Glycoprotein G of Herpes Simplex Virus 2 Induces Protective Immunity after Genital Infection
Herpes simplex virus 2 (HSV-2) infects the genital mucosa and establishes a life-long infection in sensory ganglia. After primary infection HSV-2 may reactivate causing recurrent genital ulcerations. HSV-2 infection is prevalent, and globally more than 400 million individuals are infected. As clinic...
Main Authors: | Karin Önnheim, Maria Ekblad, Staffan Görander, Tomas Bergström, Jan-Åke Liljeqvist |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-04-01
|
Series: | Viruses |
Subjects: | |
Online Access: | http://www.mdpi.com/1999-4915/8/4/110 |
Similar Items
-
Anti-Glycoprotein G Antibodies of Herpes Simplex Virus 2 Contribute to Complete Protection after Vaccination in Mice and Induce Antibody-Dependent Cellular Cytotoxicity and Complement-Mediated Cytolysis
by: Staffan Görander, et al.
Published: (2014-11-01) -
Identification of the Cleavage Domain within Glycoprotein G of Herpes Simplex Virus Type 2
by: Kai A. Kropp, et al.
Published: (2020-12-01) -
Characterization of herpes simplex virus clinical isolate Y3369 as a glycoprotein G variant and its bearing on virus typing
by: Stewart Amanda, et al.
Published: (2011-06-01) -
Herpes Simplex Virus Type 2 Mucin-Like Glycoprotein mgG Promotes Virus Release from the Surface of Infected Cells
by: Edward Trybala, et al.
Published: (2021-05-01) -
Herpes Simplex Virus Glycoprotein C Regulates Low-pH Entry
by: Tri Komala Sari, et al.
Published: (2020-02-01)